Insider Trading History of Kay E Gerald

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Kay E Gerald since 2005. The trader's CIK number is 1053310. At the time of the last reporting, Kay E Gerald was the Chairman and CEO of Integrated Biopharma Inc. (stock ticker symbol INB). Also see all insider trading activities at Integrated Biopharma Inc.

Note that in the past KAY E GERALD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ibio, Inc. (IBIO) by Kay E Gerald

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 IBIO 0 $0 190,900 $146,929 0 $0
2011 IBIO 0 $0 250,000 $125,000 0 $0

Yearly summary of insider trading at Integrated Biopharma Inc (INBP.OB) by Kay E Gerald

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 INBP.OB 0 $0 250,000 $22,500 0 $0
2005 INBP.OB 5,000 $32,200 0 $0 0 $0


Insider trading activities at 2 companies by Kay E Gerald:

1. Ibio, Inc. (IBIO)

2. Integrated Biopharma Inc (INBP.OB)

Table 1. Insider trading of Ibio, Inc. (IBIO) by Kay E Gerald

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-06-27 IBIO Sale 150,000 .76 114,000
2012-01-30 IBIO Sale 20,000 .86 17,260
2012-01-27 IBIO Sale 10,000 .79 7,930
2012-01-26 IBIO Sale 10,900 .71 7,739
2011-04-12 IBIO Sale 250,000 .50 125,000

Table 2. Insider trading of Integrated Biopharma Inc (INBP.OB) by Kay E Gerald

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-06-27 INBP.OB Sale 250,000 .09 22,500
2005-03-22 INB Buy 5,000 6.44 32,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kay E Gerald (Chairman and CEO of Integrated Biopharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.